Meeting Banner
Abstract #1870

Development of a Novel Target Moiety of SPIO Contrast Agent for Effectively Targeting to Pancreatic Cancer Cells in Vitro and in vivo

YunMing Wang1, ShouCheng Wu1, YuJen Chen1

1Department of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan

We developed an MR/optical imaging contrast agents for the diagnosis and treatment of pancreatic cancer. A highly sensitive and specific T2 weighted MR-optical imaging agent has been synthesized. The results of the experiments show significant negative contrast enhancement in mucin4 positive cell lines. As a result, we demonstrated that the T2 weighted MR-optical imaging agent can specifically target mucin4 and can be potentially used for the detection of pancreatic cancer.

Keywords

ability abstract abundantly accumulation agent agents among anticipated bearing besides binding biological bound cancer cancers cause cell cells characterize chosen confirming confocal consistent contrast control deadly death detection developed development diagnose diagnosis difficult diseases early effectively emission enhancement enhancer equation excitation experiment exploited expressed expressing expression family fluorescence gene herein highly in vivo incubated indicated indicating infused injection intensity investigated laser little major materials membrane mice moiety molecular national negative novel nude optical pancreatic positive post potential potentially protein recent reducing reflecting report scanning science sensitive serves significantly slight specifically specificity strong studied studies successfully summary survival synthesized system target targeted targeting technology therapy treatment tumor tumors tung uptake various vitro wavelength whereas year